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Abstract
Depression has been hypothesized to be a risk factor of cancer, especially hormone related 
cancers. However, few studies have been conducted with large enough sample size and sufficient 
follow up period to rigorously estimate these associations. We aim to examine the relationship 
between depression and risk of registry documented overall and hormone related cancers. In this 
19 year prospective cohort study of general population, 601,775 Koreans aged 30 64 years had a 
biennial medical evaluation by the National Health Insurance Service in either 1992 or 1994. 
Major and minor depression was ascertained by a 9 item depression questionnaire. At baseline, 
major depression was identified in 7.4% and 10.2% and minor depression in 19.3% and 21.4% in 
men and women, respectively. During the follow up, 49,744 cancers were identified in men and 
7860 in women. Prostate cancer in men was positively related to minor depression (HR 1.13, 95% 
CI 1.05, 1.23), and cervical cancer in women was inversely related to major depression (HR 0.90, 
95% CI 0.83, 0.98) after adjusting for potential confounders. Regarding overall cancer, major 
depression was positively related to overall cancer in men (HR 1.04, 95% CI 1.00, 1.08) and 
inversely related in women (HR 0.90, 95% CI 0.83, 0.98). There was no association between 
breast cancer and depression. Different direction and magnitude of association among gender and 
cancer subtypes suggest different psycho behavioral and biological pathways in which depression 
may affect later cancer development. Further studies on the association of depression and cancer 
and the underlying mechanisms should be conducted on specific cancer subtypes.
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1. Introduction
Depression, psychiatric disorder characterized by extremely low mood and loss of interest in 
activities of daily life, is associated with biological alterations including increased cortisol 
levels and absence of normal cortisol suppression response (Belmaker and Agam, 2008). 
The lifetime prevalence of major depressive disorder, a severe form of depression, has been 
estimated to affect 14.6% in high income countries and 11.1% in low income countries 
(Bromet et al., 2011). In US, the lifetime prevalence of major depressive disorder is more 
than 12% in men and 20% in women (Kessler et al., 2003). Although the prevalence of 
depression in Eastern countries, including Korea, is somewhat lower than Western countries 
(Chang et al., 2008), it has been increasing rapidly during the past decade, from 4.0% in 
2001 to 6.7% in 2011 (Cho, 2011). Depression is associated with substantial morbidity not 
only due to the disability associated with symptoms (World Health Organization, 2008), but 
also associations with chronic physical illness (Pan et al., 2011; Campayo et al., 2010). 
Understanding the full magnitude of the relation between depression and physical health is 
critical for public health, given the high prevalence and associated with disability of 
depression worldwide.
While depression is robustly associated with chronic illnesses with an inflammatory 
pathway such as stroke (Pan et al., 2011), cardiovas cular disease (Nicholson et al., 2006), 
diabetes mellitus (Campayo et al., 2010), fibromyalgia and chronic pain (Van Houdenhove 
et al., 2010) associations with outcomes such as cancer remain unresolved (Spiegel and 
Giese Davis, 2003). A recent meta analysis reported that depression presents a small and 
marginally significant association with subsequent overall cancer risk, but associations 
among different studies show considerable heterogeneity (Oerlemans et al., 2007). Among 
various subtypes of cancer, hormone related cancers have received most interest due to a 
number of plausible pathways hypothesized (Oerlemans et al., 2007). Hormone related 
cancers include breast cancer, prostate cancer, and endometrial and cervical cancer, and 
several potential mechanisms through which depression may influence the development of 
these cancers have been posited. Potential mechanisms include a role of sex hormones in 
both cancer and depression, dysregulation of hypothalamic pituitary adrenal (HPA) axis, 
increased cortisol response, and immunological and inflammatory pathways, and inhibition 
of DNA repair mechanisms (Spiegel and Giese Davis, 2003).
Inference from the literature on depression and hormone mediated cancer has been inhibited 
by several major limitations of existing data, suggesting that a gap in our understanding of 
depres sion and cancer remains unfulfilled. First, most studies have a follow up period of 
less than 20 years (Aro et al., 2005; Nyklicek et al., 2003), which are not long enough to 
detect many tumor with slow average growth patterns (Zonderman et al., 1989; Penninx et 
al., 1998). Second, a relatively small sample size limits the ability to analyze the data 
stratified by gender and specific cancer sites. In most studies, overall cancer incidence 
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among the depressed subjects does not exceed 100, with studies examining the subtypes of 
cancer resulting in even smaller incidences (Oerlemans et al., 2007; McGee et al., 1994), 
thus limiting the ability to uncover the association between depression and subsequent 
cancers. To maximize the power, most studies did not analyze by subtypes but examined 
overall cancer morbidity or mortality (Zonderman et al., 1989; Chen and Lin, 2011), which 
might result in over or under representation of association of depression and subsequent 
cancer risk. Moreover, there is no report to date on stratified analysis by gender, although 
the prevalence and risk factors for depression and cancer differ substantially across gender 
(Long et al., 2010). Third, depression was usually assessed at one time point, although it is 
the chronicity of the condition that is thought to underlie the pathways associating 
depression with cancer. Only one study known to authors examined chronic depression as an 
exposure and reported a significant association with overall cancer incidence (Penninx et al., 
1998). Finally, the biological covariates were rarely adjusted in previous studies.
While cancer incidence is relatively rare in the population, given the high prevalence of 
depression, even a small association may translate into a major attributable risk for hormone 
mediated cancers. In effort to examine the relationship between depression and subsequent 
hormone mediated cancer risk, we use data from Korean Cancer Prevention Study (KCPS) 
to resolve these limitations. This cohort includes over 600,000 subjects, which allows us to 
analyze it by gender and specific cancer. In this study, we aim to investigate whether 
persons with major and minor depression were subsequently at higher risk of developing 
overall and hormone mediated cancer than persons without depressive symptoms.
2. Methods
2.1. Study subjects
The KCPS is a cohort study of South Korean workers and their dependants. Eligible 
participants were insured by the Korean Medical Insurance Service and underwent a 
biennial medical assessment during 1992 1995 (baseline). Since the study used routinely 
obtained data, consent was not required. The study was approved by institu tional review 
boards at Yonsei University (Seoul, South Korea).
From the KCPS cohort, we included 1,220,697 individuals (797,959 men and 422,738 
women) aged 30 64 years who participated in the biennial medical evaluation offered 
routinely by the Korean National Health Insurance Service from 1992 to 1995. Of the 4 
years of consecutive evaluation, depression questionnaire (Chang et al., 2013) was included 
in 1992 and 1994 examination, with 623,419 participants. Among them, 19,050 (3.1%) with 
missing information were excluded. A total of 2594 people reporting a history of any form 
of cancer and who died in the interval between questionnaire completion and start of follow 
up on January 1 of the subsequent year were also excluded. Of the participants, 601,775 
(502,297 men and 99,478 women) were included in the final sample.
A subgroup of 546,514 participants (458,836 men and 87,678 women) who had undertaken 
both biennial examinations in 1992 and 1994 survey was analyzed separately to examine the 
relation ship between chronic depression and later cancer incidence.
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2.2. Depression ascertainment
A short questionnaire was developed to assess depression. (Table 1). The construction of the 
questionnaire was based on the diagnostic criteria of Major Depressive Episode in 
Diagnostic and Statistical Manual of Mental Disorder 4th edition (DSM IV) (American 
Psychiatric Association, 1994). Items contained within the questionnaire drew on the Patient 
Health Questionnaire 9 (PHQ 9), an instrument used widely for evaluation of depression 
(Spitzer et al., 1999). Study subjects reported whether they were experiencing each of the 
nine depressive symptoms (yes/no answer). The response was based on current rather than 
prior state with no specific time frame of reference. Major depression was denoted as a 
positive response to at least one of the first two items (“Depressed mood” or “Loss of 
interest”), plus positive responses to at least five of the all nine items. Minor depression was 
denoted by a positive response to at least one of the two items but a total of less than five 
positive responses to the total of nine items. Concurrent validity of the questionnaire was 
examined by relating data to known socio demographic and behavioral correlates of 
depression, and predictive validity was presented by relating the scores from the 
questionnaire to the occurrence of future hospitalization for depression (Chang et al., 2013). 
Among a subset of the sample that undertook surveys in both 1992 and 1994, additional 
analysis was performed to examine whether chronic depression was defined as having major 
depression in both 1992 and 1994 surveys.
For further analysis, we divided major depression and minor depression into four categories. 
Major depression was divided into severe depression (a positive response to at least one of 
the first two items plus positive responses to at least seven of the all nine items) and 
moderate depression (a positive response to at least one of the first two items plus positive 
responses to five or six of the all nine items). Minor depression was divided into mild 
depression (a positive response to at least one of the first two items plus positive responses 
to three or four of the all nine items) and some depression (a positive response to at least one 
of the first two items plus positive responses to one or two of the all nine items).
2.3. Ascertainment of cancer
Cancer incidence, the primary outcome of interest, was ascer tained by National Cancer 
Registry data and hospitalization records from the medical insurance claims (MIC) data. 
Interna tional Classification of Diseases, Tenth Revision, used to ascertain cancer incidence 
and site are as follows: C50 Breast; C53 Cervix; C54 Corpus uteri; C56 Ovary; and C61 
Prostate. The follow up period was up to December, 2012.
2.4. Other covariates
Covariates were collected from the biennial medical evaluation offered by the Korean 
National Health Insurance Corporation con ducted in 1992. It was conducted by medical 
staff at local hospitals and followed a standard procedure. Following variables were self 
reported and was used as categorical variable: Age (30 34, 35 39, 40 44, 45 49, 50 54, 55 59, 
and 60 64), marital status (married, never married, and else), smoking status (non smoker, ex 
smoker, and current smoker), drinking status (non drinker, 0 25, 25 50, 50 100, and more 
than 100 g/day), regular exercise (regular exercise, and no exercise), and cancer family 
history (yes or no). Socio economic status was measured by the insurance premium paid by 
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the employees to their medical insurance scheme. This financial mean is calculated based on 
employee's income plus assets, such as ownership of property and automobiles, and was 
divided into four quartile groups. Physical and laboratory examinations were con ducted to 
collect body mass index (kg/m2), total cholesterol, fasting blood sugar, and hypertension.
2.5. Statistical analysis
To assess the independent effects of depression status on cancer incidence, Cox proportional 
hazard models were used. In model, age, demographics (marital status and socioeconomic 
status), health behaviors (smoking status, alcohol drinking, exercise and BMI) and 
biological indicators of subclinical illness (total cholesterol, blood sugar and hypertension) 
were adjusted to express the independent effects of depression status. In Cox proportional 
hazard models, participants with major and minor depression were compared with 
participants without any depression, and participants with chronic depression were 
compared with participants who were not depressed in both 1992 and 1994. All analyses 
were performed using SAS statistical software version 9.2 (SAS Institute, Cary, NC, USA). 
All statistical tests were two sided and statistical significance was determined as p>0.05.
3. Results
The population was evenly distributed between 30 and 64 years old, with approximately five 
times as many men as women (Table 1). Among 502,297 men and 99,478 women, 7.4% and 
10.2% were identified as having major depression, respectively. Men were mostly married, 
while majority of women were single. Both smoking and alcohol use were substantially 
more common in men.
A subgroup of sample who had undertaken biennial examina tion at both 1992 and 1994 
survey was analyzed separately to examine the relationship between chronic depression and 
later cancer incidence. Among 458,836 men and 87,678 women, 14,931 (3.3%) men and 
3947 (4.5%) women were identified with chronic depression, defined as exhibiting major 
depression in both 1992 and 1994 survey, respectively. Chronically depressed individuals 
were more likely to be neither married nor never married, lower in socioeconomic status, 
current smokers and heavy drinkers, and not regularly exercising (Table 2).
3.1. Depression and subsequent overall cancer incidence
A total of 49,744 cancer incidence occurred among men and 7860 among women during the 
20 years of follow up (Table 3). Overall cancer in men was significantly associated with 
major depression (HR 1.05, 95% CI 1.01, 1.09) and minor depression (HR 1.03, 95% CI 
1.01, 1.06) compared to participants with no depres sion at all, after controlling for age, 
smoking status, alcohol drinking, exercise, BMI, cholesterol, blood sugar, hypertension, and 
cancer family history. In the contrast, overall cancer in women was inversely related to 
major depression (HR 0.90, 0.83, 0.98) and minor depression (HR 0.99, 95% CI 0.93, 1.05). 
Chronically depressed sample compared to those who were never depressed showed similar 
results, with men demonstrating positive associa tion (HR 1.08, 95% CI 1.02, 1.14) and 
women showing an inverse trend (HR 0.91, 95% CI 0.80, 1.30) with chronic depression and 
subsequent overall cancer incidence (Table 4).
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Overall cancer demonstrated clear monotonic relationship with the severity of depression 
(Table 5). In men, subjects with severe depression showed largest magnitude of association 
(HR 1.10, 95% CI 1.02, 1.18, moderate depression: HR 1.03, 95% CI 0.99, 1.08, mild 
depression: HR 1.04, 95% CI 1.01, 1.07, and some depression: HR 1.02, 95% CI 0.99, 1.06: 
p for trend 0.0483). An inverse dose response relationship between the severity of 
depression and overall cancer was clear in women (severe depression: HR 0.81, 95% CI 
0.69, 0.96, moderate depression: HR 0.93, 95% CI 0.84, 1.02, mild depression: HR 0.98, 
95% CI 0.79, 1.03, and some depression: HR 1.00 (0.91, 1.09): p for trend 0.0446).
3.2. Depression and subsequent hormone related cancer incidence
Prostate cancer in men was positively associated with major depression (HR 1.13, 95% CI 
0.98, 1.29) and minor depression (HR 1.13, 1.05, 1.23). When depression was sub 
categorized into four levels, there was a linear trend between the severity of depression and 
prostate cancer (severe depression HR 1.23, 95% CI 0.94, 1.60, moderate depression: HR 
1.09, 95% CI 0.84, 1.02, mild depression: HR 1.19, 95% CI 1.08, 1.32, and some 
depression: HR 1.07, 95% CI 0.96, 1.19).
Cervical cancer in women was inversely associated with major depression (HR 0.63, 95% 
CI 0.45, 0.90). Chronically depressed women showed about half hazard compared to never 
depressed women (HR 0.51, 95% CI 0.28, 0.93).
Breast cancer, endometrial cancer and ovarian cancer were not related to depression. (The 
results for association between depres sion and all subtypes of cancer except hormone 
related cancer are shown in Supplementary Tables 1 and 2.)
4. Discussion
In this study, we aimed to investigate the relationship between depression and the risk of 
developing overall and hormone mediated cancer. Overall cancer morbidity was positively 
asso ciated with depression in men, while inversely associated in women. Regarding 
hormone related cancer, depression was asso ciated with increased risk of prostate cancer in 
men and decreased risk of cervical cancer in women. Breast cancer, endometrial cancer and 
ovarian cancer were not related to depression. Differ ent directions of relationship of 
depression and subsequent cancer incidence between men and women may provide insights 
on the etiological theories for the relation between depression and cancer.
Our results on the association between depression and overall cancer in men are consistent 
with previous studies which have shown positive associations of small magnitude between 
depres sion and cancer (Oerlemans et al., 2007; Gross et al., 2010). Most of the previous 
studies, however, have not had sufficient sample size to rigorously demonstrate the precision 
of these estimates nor analyze specific cancer subtypes of lower incidence (Zonderman et 
al., 1989; Liang et al., 2011). The KCPS, with more than 600,000 individuals participating, 
confirms these previous results with statistical precision.
In this study, the incidence of prostate cancer was significantly increased in subjects with 
depression. In general, few studies that have examined prostate cancer as a potential 
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outcome of depres sion have documented positive association that did not reach statistical 
significance. For example, in a 24 year follow up cohort study of Baltimore, subjects with 
dysphoric episodes showed a hazard ratio of 1.39 (95% CI 0.51, 3.80) compared to the 
controls (Gross et al., 2010). In similar studies that used medical records as the depression 
measure, the rate ratio of subjects with major depressive disorder developing prostate cancer 
was 1.02 (95% CI 0.84, 1.23) and 1.33 (95% CI 0.79, 2.23) in Denmark (Dalton et al., 
2002). and Taiwan (Liang et al., 2011), respectively. In another study, chronically depressed 
older subjects showed an increased morbidity of prostate cancer although not statistically 
significant (HR 1.47, 95% CI 0.20, 10.83) (Penninx et al., 1998). In a meta analysis that 
combined three studies, statistical pooling revealed an estimated summary adjusted relative 
risk of 1.60 (95% CI 0.40, 6.50). Our results, which used a sample with 260 cancer 
incidences among subjects with major depression, are the first to show a statistically 
significant association between depression and sub sequent prostate cancer risk. 
Furthermore, a trend of dose response relationship between depression and prostate cancer 
supports the robustness of association.
Literature on the effect of depression on cervical cancer is even scarcer. However, in one 
study conducted in Denmark, being hospitalized for depression was found to be a protective 
factor against cervical cancer incidence, with a standardized incidence ratio of 0.81 (95% CI 
0.65, 0.99) (Dalton et al., 2002). Our result shows significantly decreased incidence of 
cervical cancer among women with depression. The mechanism in which depression is 
protective against cervical cancer is unknown. Human papilloma virus (HPV) is a necessary 
cause of cervical cancer (Walboomers et al., 1999), suggesting that HPV may be a 
mechanism through which depression influences cervical cancer risk. However, exist ing 
studies on the relation between depression and HPV are mixed; some studies document 
lower depressive and anxiety symptoms among affected men and women (Johnson et al., 
2011), though other studies show that women with HPV have higher levels of psychological 
distress once their status is known (Graziottin and Serafini, 2009; Clarke et al., 1996). Major 
depres sion is known to negatively influence sexual functioning, suggest ing that women 
with chronic major depression may be at lower risk for HPV infection and thus subsequent 
development of cervical cancer. Further research into these findings is critical.
Breast cancer is one of the most extensively studied subtypes regarding its association with 
depression. Some reported positive association (Aro et al., 2005; Gross et al., 2010), while 
others showed no association or even negative relationship (Nyklicek et al., 2003). In our 
study, we found no association between depression and breast cancer. This result is 
consistent with other large sample studies that examined the relation of depression and 
breast cancer. For example, a study conducted in Finland with over 10,000 subjects (Aro et 
al., 2005) and a meta analysis of 9 studies (Oerlemans et al., 2007) also showed no evidence 
of depression being a significant predictor of breast cancer incidence. In one of the studies 
that reported a strong positive association in a 24 year cohort study ascertained breast cancer 
by self report (Gross et al., 2010), which may bias the association away from the null. In 
another study showing a positive relationship, extreme stress and severe chronic depression 
was found to be a significant predictor of later breast cancer (Jacobs and Bovasso, 2000), 
which suggests that a certain threshold of severity might exist in the relation of depression 
and subsequent breast cancer.
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Several mechanisms may be hypothesized for the association between depression and 
subsequent cancer (Spiegel and Giese Davis, 2003). One plausible pathway involves the 
hypothalamic pituitary adrenal (HPA) axis. There is considerable evidence that cortisol, a 
stress hormone that is released into plasma when stress is perceived, is associated with 
depression. Patients with depres sion show elevated cortisol levels in plasma (Burke et al., 
2005) and display aberrant response to dexamethasone suppression test (Carroll et al., 2012). 
At the same time, cortisol is also involved in the activation of signaling that controls cell 
growth and regulation of the cell cycle.
Alteration in cytokine secretion and regulation is another possible pathway in which 
depression may be associated with subsequence cancer. Depression is common in infectious 
and autoimmune dis eases, and cytokine secretion is increased in major depression (Goshen 
et al., 2008). Also cytokines affect the HPA axis and monoamines (Goshen et al., 2008). At 
the same time, dysfunctional immune responses, including increased concentrations of 
cytokines TNF α and IL 6, are reported in patients with cancer (Lippitz, 2013).
Cultural factors may also influence the association between depression and cancer. 
Prevalence of mental disorders, including depression, tends to be lower in Asian countries 
compared to Western world (Chang et al., 2008). This may be due to unwill ingness to 
disclose information about personal difficulties and result in identifying more severe cases 
with stronger association with subsequent physical disease.
Compared to previous studies examining the association between depression and subsequent 
cancer risk, this study has several important strengths. First, this is the study with the largest 
sample size of more than 600,000 individuals. This is the largest prospective cohort study on 
the effect of depression on cancer. Because of its large sample size, the analysis had enough 
statistical precision to identify the relationship between depression and each subtypes of 
cancer, stratified by gender. Secondly, a follow up period of 20 years is longer than most of 
the other studies (Aro et al., 2005; Nyklicek et al., 2003; Zonderman et al., 1989). Due to 
slow growing rate of tumors, a follow up period of less than 10 years may be too short to 
detect an effect of depression on cancer incidence. For example, breast cancer with an 
average tumor volume doubling time of 280 days needs more than 18 years to grow from the 
first tumor cell to a tumor that is detectable (Possel et al., 2012; Friberg and Mattson, 1997). 
In their meta analysis, Oerlemans et al. reported that studies with follow up period of more 
than ten years were more likely to show significant associa tion between depression and 
subsequent overall and breast cancer risk (Oerlemans et al., 2007). Thirdly, cancer was 
ascertained by registry independent of exposure by linkage, and not self reported. Since 
depression is known to color perception of subject, self report on cancer diagnosis may bias 
the relationship further away from the null. Fourth, chronicity was examined.
There are also limitations to be noted. The method of ascertaining depression is a common 
limitation in studies examining depression. In our study, we used a self reported 
questionnaire to assess the level of depression in this large group of subjects. Although 
diagnosis by specialist or standardized diagnostic interviews is thought of as more valid 
measure of depression, self reported questionnaires are more convenient and inexpensive, 
thus allowing relatively large numbers of people to be evaluated in an epidemiological 
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study. Moreover, in Asian countries with a culture of unwillingness to disclose informa tion 
about personal difficulties, anonymity provided by questionnaire may allow participants to 
be more freely open about their mood status. Furthermore, medical diagnosis or 
standardized interview generally assess only the most severe form of depression such as 
major depressive disorder, while self reported questionnaires that are usually devised for 
screening purposes may identify individuals with minimal depressive symptoms as well as 
those with severe mood disorders. Finally, some of the potential confounders were not 
included in the analysis. Screening behavior in depressed subjects may account for positive 
association between depression and later cancer diagnosis. Also, data on potential 
confounders specific to hormonal cancers, such as parity, menopause, and hormone therapy 
was not collected in this study.
In conclusion, depression was associated with increased risk of prostate cancer among men 
and decreased risk of cervical cancer among women. The KCPS, with more than 600,000 
individuals participating for almost 20 years, allows for statistical power to examine the 
association between depression and each subtypes of cancer, stratified by gender. Different 
direction and magnitude of association among gender and cancer subtypes suggest different 
psycho behavioral and biological pathways in which depression may affect later cancer 
development. Further studies on the association of depression and subsequent cancer and the 
underlying mechanisms should be conducted on specific cancer subtypes.
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Table 1
Demographic characteristics major and minor depression in 1992 in South Korea, by gender, n (%).
Men Women
All
n = 
502,297
Major depressiona
7.4%
Minor depressionb
19.3%
Not depressed
73.3%
All
n=99,478
Major 
depression
a
 10.2%
Minor 
depression
b
 21.4%
Not depressed
68.4%
Age (year)
 30–34 11,4017 7.6% 14.3% 78.1% 41,444 10.2% 20.8% 69.0%
 35–39 11,3663 7.9% 16.3% 75.8% 25,164 9.8% 20.6% 69.6%
 40–44 86,861 7.8% 18.7% 73.5% 16,009 10.0% 21.2% 68.7%
 45–49 72,509 7.6% 21.3% 71.1% 8243 11.7% 23.1% 65.7%
 50–54 66,836 6.8% 24.7% 68.5% 5437 11.6% 25.6% 62.8%
 55–59 39,812 6.0% 27.8% 66.2% 2616 9.0% 25.5% 65.5%
 60–64 8599 5.5% 30.2% 64.3% 565 7.1% 20.2% 72.7%
Marital status
 Married 475,916 7.3% 19.3% 73.4% 10,026 10.1% 21.7% 68.2%
 Never
  married
15,216 10.1% 15.5% 74.5% 85,396 10.6% 18.6% 70.8%
 Else 8012 10.8% 23.2% 66.0% 3576 11.7% 22.1% 66.0%
Socioeconomic status
 1 St Quartile 102,577 7.9% 21.0% 71.1% 11,887 10.4% 21.6% 68.0%
 2nd Quartile 92,991 7.6% 20.1% 72.3% 14,587 10.7% 21.5% 67.8%
 3rd Quartile 107,286 7.6% 17.7% 74.7% 33,337 9.8% 21.4% 68.9%
 4th Quartile 107,156 6.4% 19.3% 74.3% 20,947 10.2% 22.1% 67.7%
Smoking status
 Non smoker 104,435 5.6% 16.8% 77.6% 98,849 10.2% 21.4% 68.4%
 Ex smoker 98,676 7.1% 20.1% 72.8% 383 13.6% 24.8% 61.6%
 Current
  smoker
299,186 8.2% 19.9% 72.0% 246 15.0% 17.1% 67.9%
Drinking status
 Non drinker 97,612 7.1% 18.2% 75.5% 83,732 9.5% 21.0% 69.5%
 0–25 g/d 282,820 6.8% 18.9% 74.3% 15,562 13.9% 23.4% 62.7%
 25–50 g/d 73,124 8.3% 20.5% 71.2% 145 16.6% 25.5% 57.9%
 50–100 g/d 36,973 11.5% 21.8% 66.7% 28 7.1% 32.1% 60.7%
 100-g/d 11,768 14.2% 21.6% 64.2% 11 0.0% 27.3% 72.7%
Regular exercise
 Regular
  exercise
138,203 4.4% 16.7% 78.9% 12,480 7.4% 18.5% 74.0%
 No exercise 364,094 8.6% 20.2% 71.2% 86,998 10.6% 21.8% 67.6%
a
Major depression: (item 1 or item 2) and (at least 5 positive answers among 9 items).
b
Minor depression: (item 1 or item 2) and (1–4 positive answers among 9 items).
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Table 2
Demographic characteristics of subjects with chronica major depression, n (%).
Men Women
All n = 
458,836
Chronic major
depressiona 
3.3%
Never depressedb
96.7%
All n=87,678 Chronic major
depressiona 
4.5%
Never depressedb
95.5%
Age (year)
 30–34 103,574 3.2% 96.8% 36,435 4.3% 95.7%
 35–39 103,392 3.5% 96.5% 22,275 4.3% 95.7%
 40–44 79,085 3.5% 97.1% 14,132 4.2% 95.8%
 45–49 66,223 3.3% 96.7% 7191 6.0% 93.9%
 50–54 61,547 3.0% 97.0% 4758 5.8% 94.2%
 55–59 36,988 2.4% 97.6% 2363 4.1% 95.9%
 60–64 8027 2.4% 97.6% 524 3.6% 96.4%
Marital status
 Married 435,315 3.2% 96.8% 75,278 4.5% 95.5%
 Never married 13,500 4.4% 95.6% 8863 4.3% 95.7%
 Else 7133 5.5% 94.5% 3113 5.2% 94.8%
Socioeconomic status
 1 St Quartile 93,291 3.6% 96.4% 10,470 4.8% 95.2%
 2nd Quartile 84,616 3.3% 96.7% 12,847 5.0% 95.0%
 3rd Quartile 97,902 3.3% 96.7% 29,423 4.0% 96.0%
 4th Quartile 99,066 2.7% 97.3% 18,523 4.5% 95.5%
Smoking status
 Non smoker 97,300 2.3% 97.7% 87,150 4.5% 95.5%
 Ex smoker 90,584 2.9% 97.1% 328 4.6% 95.4%
 Current smoker 270,952 3.7% 96.3% 200 7.0% 93.0%
Drinking status
 Non drinker 90,417 2.5% 97.5% 74,301 4.1% 95.9%
 0-25 g/d 259,650 2.9% 97.1% 13,226 6.8% 93.2%
 25-50 g/d 66,103 3.8% 96.2% 118 7.6% 92.4%
 50-100 g/d 32,533 5.7% 94.3% 26 3.8% 96.2%
 100-g/d 10,133 7.4% 92.6% 7 0.0% 100.0%
Regular exercise
 Regular exercise 130,010 1.7% 98.3% 11,297 2.9% 97.1%
 No exercise 328,826 3.9% 96.1% 3,619 4.7% 95.3%
aChronic major depression=major depression in 1992 and major depression in 1994, among those who were interviewed at both waves.
bNever depressed = not depressed in 1992 and not depressed in 1994.
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Table 3
Hazard ratios and 95% confidence intervals for associations between cancer subtypes diagnosed between 1993 
and 2012, major depression, and minor depression in 1992.
Major depression
(ref: everybody else)
Number 
of cancer
morbidity 
at
follow-up
Number 
with
major 
depression
Major depression
Unadjusted 
HR (95% CI)
Model 1 Model 2 Model 3 Model 4
Major depression
Men
 Total cancer 49,744 3661 1.05 (1.02–1.09) 1.09 (1.06–1.13) 1.05 (1.02–1.09) 1.05 (1.02–1.09) 1.05 (1.01–1.09)
 Prostate cancer (C61) 3811 260 1.01 (0.99–1.14) 1.07 (0.94–1.21) 1.12 (0.98–1.27) 1.12 (0.98–1.27) 1.13 (0.98–1.29)
Women
 Total cancer 7860 751 0.93 (0.86–1.01) 0.92 (0.85–1.00) 0.93 (0.86–1.00) 0.93 (0.86–1.00) 0.90 (0.83–0.98)
 Breast cancer(C50) 2244 234 1.00 (0.88–1.15) 1.00 (0.87–1.15) 1.00 (0.87–1.14) 1.00 (0.87–1.14) 0.98 (0.98–1.14)
 Cervical cancer(C53) 588 141 0.73 (0.54–1.00) 0.72 (0.53–0.99) 0.72 (0.53–0.98) 0.72 (0.52–0.98) 0.63 (0.45–0.90)
 Endometrial cancer (C54) 203 47 0.77 (0.46–1.29) 0.76 (0.45–1.27) 0.77 (0.46–1.30) 0.77 (0.46–1.30) 0.69 (0.39–1.21)
 Ovarian cancer (C56) 300 75 1.11 (0.76–1.62) 1.10 (0.76–1.60) 1.10 (0.76–1.60) 1.11 (0.76–1.61) 1.03 (0.68–1.56)
Minor depression
Men
 Total cancer 49,744 11,447 1.29 (1.26–1.31) 1.06 (1.04–1.09) 1.04 (1.01–1.06) 1.03 (1.01–1.06) 1.03 (1.01–1.06)
 Prostate cancer (C61) 3811 983 1.48 (1.38–1.60) 1.11 (1.03–1.19) 1.13 (1.05–1.22) 1.14 (1.06–1.22) 1.13 (1.05–1.23)
Women
 Total cancer 7860 1719 1.02 (0.97–1.08) 1.00 (0.95–1.06) 1.00 (0.95–1.06) 1.00 (0.95–1.06) 0.99 (0.93–1.05)
 Breast cancer(C50) 2244 448 0.92 (0.82–1.02) 0.92 (0.83–1.02) 0.92 (0.83–1.02) 0.92 (0.83–1.02) 0.92 (0.82–1.03)
 Cervical cancer(C53) 588 403 1.12 (0.92–1.36) 1.10 (0.91–1.33) 1.10 (0.91–1.33) 1.10 (0.91–1.33) 1.03 (0.84–1.27)
 Endometrial cancer (C54) 203 140 1.07 (0.77–1.49) 1.07 (0.77–1.49) 1.08 (0.78–1.51) 1.08 (0.78–1.51) 1.11 (0.79–1.57)
 Ovarian cancer (C56) 300 193 1.24 (0.95–1.62) 1.23 (0.94–1.61) 1.22 (0.94–1.60) 1.22 (0.94–1.60) 1.24 (0.93–1.64)
Model 1: adjusted for age, marital status, SES (demographics).
Model 2: adjusted for age, smoking status, alcohol drinking, exercise, BMl (demographics+health behaviors).
Model 3: adjusted for age, smoking status, alcohol drinking, exercise, BMI, cholesterol, blood sugar, hypertension (demos+health behaviors
+biological indicators of subclinical illness).
Model 4: adjusted for age, smoking status, alcohol drinking, exercise, BMI, cholesterol, blood sugar, hypertension, and cancer family history 
(demos+health behaviors+biological indicators of subclinical illness + genetic liability).
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Table 4
Hazard ratios and 95% confidence intervals for associations between cancer subtypes diagnosed between 1993 
and 2012 and chronic depression in 1992 and 1994.
Chronic depression
(ref: everybody else)
Number 
of cancer
morbidity 
at
follow-up
Number 
with
chronic
depression
Chronic depression
Unadjusted 
HR (95%
CI)
Model 1 Model 2 Model 3 Model 4
Men
 Total cancer 45,516 1510 1.03 (0.98–1.08) 1.12 (1.06–1.18) 1.07 (1.02–1.13) 1.07 (1.02–1.13) 1.08 (1.02–1.14)
 Prostate cancer (C61) 3499 99 0.87 (0.71–1.06) 1.00 (0.82–1.22) 1.05 (0.86–1.28) 1.05 (0.86–1.28) 1.05 (0.85–1.30)
Women
 Total cancer 6980 296 0.94 (0.84–1.06) 0.92 (0.82–1.04) 0.93 (0.82–1.04) 0.93 (0.82–1.04) 0.91 (0.80–1.03)
 Breast cancer(C50) 1976 87 0.98 (0.79–1.21) 0.97 (0.78–1.21) 0.97 (0.79–1.21) 0.97 (0.78–1.21) 0.96 (0.76–1.21)
 Cervical cancer(C53) 529 13 0.53 (0.31–0.93) 0.52 (0.30–0.91) 0.52 (0.30–0.91) 0.52 (0.30–0.91) 0.51 (0.28–0.93)
 Endometrial cancer
  (C54)
181 6 0.73 (0.32–1.65) 0.71 (0.32–1.61) 0.74 (0.33–1.68) 0.74 (0.33–1.68) 0.81 (0.36–1.84)
 Ovarian cancer (C56) 269 11 0.91 (0.50–1.66) 0.88 (0.48–1.62) 0.88 (0.48–1.61) 0.88 (0.48–1.61) 0.91 (0.48–1.72)
Model 1: adjusted for age, marital status, SES (demographics).
Model 2: adjusted for age, smoking status, alcohol drinking, exercise, BMI (demographics+health behaviors).
Model 3: adjusted for age, smoking status, alcohol drinking, exercise, BMI, cholesterol, blood sugar, hypertension (demos+health behaviors
+biological indicators of subclinical illness).
Model 4: adjusted for age, smoking status, alcohol drinking, exercise, BMI, cholesterol, blood sugar, hypertension, and cancer family history 
(demos+health behaviors+biological indicators of subclinical illness + genetic liability).
aChronic major depression=major depression in 1992 and major depression in 1994, among those who were interviewed at both waves.
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Table 5
Hazard ratios and 95% confidence intervals for associations between cancer subtypes diagnosed between 1993 
and 2012, by severity of depression in 1992.
Men Women
Total cancer Prostate cancer Total cancer Breast cancer Cervical cancer Endometrial ca Ovarian cancer
Severe depression 1.10 (1.02–1.18) 1.23 (0.94–1.60) 0.81 (0.69–0.96) 0.79 (0.58–1.08) 0.69 (0.36–1.33) 1.11 (0.45–2.71) 1.14 (0.54–2.43)
Moderate depression 1.03 (0.99–1.08) 1.09 (0.93–1.27) 0.93 (0.84–1.02) 1.05 (0.89–1.23) 0.62 (0.41–0.93) 0.56 (0.27–1.14) 0.99 (0.62–1.60)
Mild depression 1.04 (1.01–1.07) 1.19 (1.08–1.32) 0.98 (0.92–1.05) 0.90 (0.79–1.03) 0.88 (0.68–1.15) 1.08 (0.72–1.63) 1.37 (0.99–1.89)
Some depression 1.02 (0.99–1.06) 1.07 (0.96–1.19) 1.00 (0.91–1.09) 0.97 (0.81–1.15) 1.32 (0.98–1.78) 1.17 (0.70–1.97) 1.00 (0.62–1.63)
p-for-trend 0.0483 0.0931 0.0446 0.3549 0.1438 0.6827 0.6709
adjusted for age, smoking status, alcohol drinking, exercise, BMl, cholesterol, blood sugar, hypertension, and cancer family history.
Severe depression: (item 1 or item 2) and (at least 7 positive answers among 9 items).
Moderate depression: (item 1 or item 2) and (5~6 positive answers among 9 items).
Mild depression: (item 1 or item 2) and (3~4 positive answers among 9 items).
Some depression: (item 1 or item 2) and (1~2 positive answers among 9 items).
Reference: No depression (not item 1) and (not item 2).
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